Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +5.86% | -0.31% | -45.27% |
04/04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
08/01 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
- Stock Market
- Equities
- MURA Stock
- News Mural Oncology plc
- MarketScreener Editorial Features